Genomed Spólka Akcyjna (WSE:GEN)
Poland · Delayed Price · Currency is PLN 39.40
0.00 (0.00%)
Last updated: Nov 10, 2026, 1:24 PM CET
Genomed Spólka Akcyjna Revenue
Genomed Spólka Akcyjna had revenue of 7.13M PLN in the quarter ending June 30, 2026, with 17.47% growth. This brings the company's total for the last twelve months to 30.64M, up 21.90% year-over-year. In the year 2025, Genomed Spólka Akcyjna had annual revenue of 29.12M with 26.58% growth. That makes Genomed Spólka Akcyjna the 38,404th largest company in the world by revenue and 351st in Poland.
Revenue (ttm)
30.64M
Revenue Growth
+21.90%
P/S Ratio
1.70
Revenue / Employee
519.39K
Employees
59
Market Cap
52.06M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Genomed Spólka Akcyjna breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.12M | 6.11M | 26.58% |
| Dec 31, 2024 | 23.01M | 525.20K | 2.34% |
| Dec 31, 2023 | 22.48M | 2.02M | 9.88% |
| Dec 31, 2022 | 20.46M | 565.09K | 2.84% |
| Dec 31, 2021 | 19.89M | 1.14M | 6.08% |
| Dec 31, 2020 | 18.75M | -919.21K | -4.67% |
| Dec 31, 2019 | 19.67M | 1.09M | 5.84% |
| Dec 31, 2018 | 18.59M | 2.23M | 13.61% |
| Dec 31, 2017 | 16.36M | 1.97M | 13.69% |
| Dec 31, 2016 | 14.39M | 4.71M | 48.73% |
| Dec 31, 2015 | 9.68M | 2.35M | 32.05% |
| Dec 31, 2014 | 7.33M | 3.47M | 89.86% |
| Dec 31, 2010 | 3.86M | 2.10M | 118.80% |
| Dec 31, 2009 | 1.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 14.14B |
| Diagnostyka | 2.58B |
| Synektik Spólka Akcyjna | 932.97M |
| Voxel | 640.61M |
| Biogened | 110.11M |
| BioMaxima | 60.64M |
| Read-Gene | 16.66M |
| MedApp | 6.75M |